文献速递生殖医学

小鼠胚胎反复玻璃化冻融对存活及移植结局的影响

Once, twice, three times frozen: viability and post-transfer outcomes of fresh and vitrified-warmed mouse embryos.
PubMed 文献 · Hum Reprod · 2026-01-01

该研究以小鼠为模型,比较新鲜与经历一、二或三次玻璃化冻融循环的囊胚在冻融存活、细胞谱系分配及移植后发育的差异。结果显示反复冻融进行性损害胚胎冻融存活、囊胚质量及两次以上循环后的胎儿生长。

要点

  • 两次或三次冻融循环后胚胎冻融存活显著下降。
  • 两次或三次循环后ICM细胞数显著减少,ICM:TE比值降低。
  • 两次或三次循环后胎儿体重及胎儿:胎盘重量比显著降低。

核心结论

  • 反复玻璃化冻融循环进行性损害小鼠胚胎冻融存活、囊胚质量及两次以上循环后的胎儿生长。

研究设计与样本

  • 采用小鼠控制性临床前模型,胚胎经IVF培养至囊胚后行零(新鲜)、一、二或三次玻璃化冻融循环。
  • 冻融存活评估样本量分别为3035、1465和447个囊胚(23次独立实验重复)。
  • ICM和TE细胞数评估样本量分别为35、36、33和28个囊胚(4次独立实验重复)。
  • 移植后结局评估样本量分别为30、33、39和22只假孕受体。

主要发现

  • 与一次循环相比,两次或三次循环后胚胎冻融存活显著降低(P < 0.05),三次循环后非存活胚胎比例显著更高(P < 0.001)。
  • 与新鲜胚胎相比,两次或三次循环后ICM细胞数显著减少(P < 0.0001),两次循环后TE细胞数增加(P < 0.05)。
  • 与新鲜胚胎相比,一、二或三次循环后ICM:TE比值均显著降低(P < 0.01)。
  • 与新鲜移植相比,一次、两次和三次循环后妊娠相对风险分别为0.74(95% CI 0.34-1.64)、0.75(95% CI 0.35-1.62)和0.59(95% CI 0.27-1.32),差异均无统计学意义。
  • 与新鲜组相比,两次和三次循环后胎儿体重显著降低(P = 0.037和P = 0.012),胎儿:胎盘重量比显著降低(P = 0.009和P = 0.002)。

临床怎么用

  • 结果提示应优化冷冻保存方案并限制不必要的再次冻融,以改善IVF中胚胎存活及胎儿结局。

局限性

  • 研究使用小鼠模型,物种差异意味着需进一步机制和转化研究评估对人类生殖的相关性。
  • 研究仅聚焦囊胚阶段胚胎,限制了发现对其他发育阶段的适用性。
  • 未单独研究冷冻保护剂暴露本身的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the impact of one, two, or three vitrification-warming cycles on embryo viability, implantation potential, and post-transfer development compared with fresh transfer? SUMMARY ANSWER: Repeated vitrification-warming cycles progressively impaired embryo cryosurvival, blastocyst quality, and foetal growth after two or more cycles. WHAT IS KNOWN ALREADY: Cryopreservation is central to embryo storage and preimplantation genetic testing, where embryos are biopsied and frozen while awaiting results. However, the impact of repeated vitrification-warming cycles remains unclear due to confounding factors including biopsy effects, prior implantation failure, the absence of a true non-cryopreserved control, and fresh transfer comparisons confounded by supraphysiological hormonal exposure. STUDY DESIGN, SIZE, DURATION: To overcome the constraints of clinical studies, this study used the mouse as a controlled preclinical model. This allowed precise experimental control over embryo stage at cryopreservation and vitrification protocol and enabled direct comparison with a non-vitrified (fresh) control group without the confounding effects of supraphysiologic hormone exposure or biopsy. While species differences are recognized, this model enables focused assessment of cryopreservation-specific effects. Outcomes included post-warming survival, cell lineage allocation, as well as post embryo transfer outcomes on Day 18.5 of development (pregnancy and implantation rates, foetal and placental weights). Post-warming survival was assessed after one, two, or three freeze-warm cycles (3035, 1465, and 447 blastocysts, respectively; 23 independent experimental replicates). Inner cell mass (ICM) and trophectoderm (TE) cell numbers were quantified following one, two, or three freeze-warm cycles and compared to a fresh (non-vitrified) control (35, 36, 33, and 28 blastocysts, respectively; four independent experimental replicates). Post-transfer outcomes were evaluated after one, two, or three freeze-warm cycles and compared to a fresh (non-vitrified) control (30, 33, 39, and 22 pseudo-pregnant recipients, respectively). Sample size calculations were performed to ensure the study was appropriately powered. PARTICIPANTS/MATERIALS, SETTING, METHODS: Murine embryos were generated following IVF and cultured to the blastocyst stage, and underwent zero (fresh), one, two, or three repeated vitrification-warming cycles. Post-warming survival was assessed morphologically, and immunohistochemistry for OCT-3/4 (ICM) and CDX2 (TE) was used to assess cell lineage allocation. Embryo transfers were used to further evaluate developmental competence with pregnancy rate, implantation outcomes (implantation rate, viable implantation rate, resorption rate), foetal and placental outcomes (foetal weight, placental weight, and the foetal-to-placental weight ratio) measured on Day 18.5 of development. MAIN RESULTS AND THE ROLE OF CHANCE: Embryo cryosurvival declined significantly with increasing numbers of freeze-warm cycles, with marked reductions after two or three cycles compared with one cycle (P < 0.05) and a substantially higher proportion of non-viable embryos after three cycles (P < 0.001). ICM cell number was significantly reduced after two or three cycles compared with fresh embryos (P < 0.0001), while TE cell number increased after two cycles (P < 0.05). The ICM:TE ratio was significantly reduced after one, two, or three cycles compared with fresh (P < 0.01). Following embryo transfer, pregnancy rates were lower in all freeze-warm groups than in fresh controls, although these differences were not statistically significant. Relative risk of pregnancy compared with fresh transfer was 0.74 (95% CI 0.34-1.64) after one cycle, 0.75 (95% CI 0.35-1.62) after two cycles, and 0.59 (95% CI 0.27-1.32) after three cycles. Implantation and viable implantation rates showed similar nonsignificant reductions, while resorption rates were numerically higher after two or three freeze-warm cycles. Compared with the fresh group, foetal weights were significantly reduced after two and three cycles (P = 0.037 and P = 0.012), placental weight showed a nonsignificant trend towards increase, and the foetal:placental weight ratio was significantly decreased after two and three cycles (P = 0.009 and P = 0.002). While cryosurvival, ICM cell number, and foetal outcomes showed clear statistical effects, the nonsignificant pregnancy, implantation, and resorption measures indicate that chance may partly explain the post-transfer variability. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The study used a murine model, and although procedures reflected clinical practice, species differences mean further mechanistic and translational studies are needed to evaluate relevance to human reproduction. Additionally, the study focused exclusively on blastocyst-stage embryos, limiting the applicability of the findings to other developmental stages. The effects of cryoprotectant exposure alone were not investigated. WIDER IMPLICATIONS OF THE FINDINGS: These findings provide quantitative evidence of the cumulative effects of repeated embryo vitrification-warming and may inform optimization of cryopreservation protocols, limit unnecessary re-freezing, and support refinement of clinical guidelines to improve embryo viability and foetal outcomes in IVF. STUDY FUNDING/COMPETING INTEREST(S): K.R.D. is supported by an Australian Research Council Future Fellowship (Adelaide University, FT240100291). The authors declare that there is no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Li T, Chow DJX, Li S, et al. Once, twice, three times frozen: viability and post-transfer outcomes of fresh and vitrified-warmed mouse embryos. Hum Reprod. 2026. PMID: 42035726. doi:10.1093/humrep/deag065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。